CDC Frees Up Drug That Fights Brain-Eating Amoeba

The CDC has implemented an expanded-access IND program with the FDA to make miltefosine available to doctors in the U.S. Miltefosine is an experimental drug that has been shown to defeat the Naegleria fowleri amoeba that recently struck two children swimming in freshwater.
Philly.com